SCHEMBL6403401

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4092864	0.90	ABL1 (0.73)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL4091524	0.88	ABL1 (0.88)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL4095048	0.86	ABL1 (0.75)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL4087864	0.85	MAPK14 (0.71)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL7244206	0.85	ABL1 (0.77)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL4081862	0.84	MAPK14 (0.70)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL4086520	0.83	ABL1 (0.72)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL3185172	0.82	ABL1 (1.00)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL4096809	0.81	MAPK14 (0.65)	ABL1RAF1LYNSRCMAPK9
	SCHEMBL13527345	0.81	ABL1 (0.76)	ABL1RAF1LYNSRCMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.